| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.RADONC.2015.11.031 |
| P698 | PubMed publication ID | 26705680 |
| P50 | author | Kjersti Flatmark | Q64222088 |
| Svein Dueland | Q88037388 | ||
| Anne Hansen Ree | Q89880872 | ||
| Therese Seierstad | Q92692149 | ||
| Kathrine Røe Redalen | Q39052016 | ||
| Beathe Sitter | Q55487435 | ||
| Tone F. Bathen | Q61104171 | ||
| P2093 | author name string | Krystyna K Grøholt | |
| Knut Håkon Hole | |||
| P2860 | cites work | Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy | Q34140986 |
| Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery | Q34684585 | ||
| Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation | Q36477750 | ||
| Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis | Q43052904 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adverse prognostic factor | Q108529003 |
| P304 | page(s) | 393-398 | |
| P577 | publication date | 2015-12-17 | |
| P1433 | published in | Radiotherapy and Oncology | Q14251029 |
| P1476 | title | High tumor glycine concentration is an adverse prognostic factor in locally advanced rectal cancer | |
| P478 | volume | 118 |
| Q54935926 | Glycine: a non-invasive imaging biomarker to aid magnetic resonance spectroscopy in the prediction of survival in paediatric brain tumours. |
| Q57067804 | Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer |
| Q52655039 | Metabolic profiling of the three neural derived embryonal pediatric tumors retinoblastoma, neuroblastoma and medulloblastoma, identifies distinct metabolic profiles. |
| Q37729169 | Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer. |
| Q58713199 | Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls |
Search more.